**Update**

Effective January 1, 2021, dispensation information for insulin drugs, glucagon drugs, diabetes devices, diabetic ketoacidosis devices, gabapentin, and naloxone are required to be uploaded into the CPMRS. All listed prescriptions will be available on patient reports except for naloxone. Only CPMRS admin will have access to naloxone data for the purpose of aggregate population analytics that will help to inform public policy. For more information, please visit the For Pharmacists webpage.

**Update**

NO-COST* CPMRS Integration. Streamline your workflow. Save Time. Focus on Patient Care.

The CPMRS can now be accessed through approved electronic health records (EHR) and pharmacy management systems (PMS) where PDMP data and NarxCare analytics will be delivered directly into your workflow. The Connecticut Prescription Monitoring Program (PMP) is pleased to announce a statewide initiative to integrate the CPMRS into approved EHR/PMS using Appriss Health’s PMP Gateway service.

For more information, navigate to CPMRS Integration to take advantage of the opportunity. For a limited of time, the *initial set-up fee and *user fees will be waived due to funding from the Centers for Medicare & Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS).

The Prescription Monitoring Program collects prescription data for Schedule II through Schedule V drugs into a centralized database, the Connecticut Prescription Monitoring and Reporting System (CPMRS), which can then be used by healthcare providers and pharmacists in the active treatment of their patients.  The purpose of the CPMRS is to present a complete picture of a patient’s controlled substance use, including prescriptions by other providers. As a healthcare tool, the CPMRS is used to improve quality of patient care and to reduce prescription abuse, addiction, and overdose. This allows providers the opportunity to properly manage the patient’s treatment, including referral of a patient to services offering treatment for drug abuse or addiction when appropriate.